This inventor holds 1 USPTO granted patent and 12 published patent applications. Top assignees: Biofront Therapeutics (Beijing) Co., Ltd., Rk Pharmtech (Beijing) Ltd.. Active years: 2024.
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2024
Title: Lichao Fang: Innovator in Cathepsin L Inhibitors
Introduction
Lichao Fang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit Cathepsin L (CatL). His innovative work has the potential to impact the treatment of various diseases related to this enzyme.
Latest Patents
Lichao Fang holds 1 patent for his work on Cathepsin L inhibitors. The patent details a range of compounds capable of inhibiting CatL, along with a composition that includes at least one of these compounds. Additionally, the patent outlines a method for treating or preventing one or more CatL-related diseases in a subject, which involves administering the composition to the subject.
Career Highlights
Throughout his career, Lichao Fang has worked with notable companies in the pharmaceutical industry. He has been associated with Biofront Therapeutics (Beijing) Co., Ltd. and Rk Pharmtech (Beijing) Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Lichao Fang has collaborated with several professionals in his field, including Yayi Wang and Tianwei Ma. These collaborations have likely enhanced his research and development efforts, leading to advancements in his work.
Conclusion
Lichao Fang is a distinguished inventor whose work on Cathepsin L inhibitors showcases his commitment to advancing medical science. His contributions have the potential to lead to significant improvements in the treatment of diseases associated with CatL.